|1.||Lefèvre, Gilbert: 4 articles (01/2013 - 03/2002)|
|2.||Sagara, Issaka: 3 articles (01/2009 - 01/2008)|
|3.||Abdulla, Salim: 3 articles (01/2009 - 01/2007)|
|4.||Looareesuwan, S: 3 articles (09/2003 - 05/2001)|
|5.||Rahman, M R: 2 articles (12/2013 - 10/2005)|
|6.||Kassa, Moges: 2 articles (12/2013 - 01/2010)|
|7.||Nzila, Alexis: 2 articles (06/2013 - 10/2012)|
|8.||Mayanja-Kizza, Harriet: 2 articles (01/2011 - 01/2010)|
|9.||Lamorde, Mohammed: 2 articles (01/2011 - 01/2010)|
|10.||Van Geertruyden, Jean-Pierre: 2 articles (01/2011 - 01/2010)|
08/01/2012 - "In order to implement community case management of malaria strategy in a rural area of intense transmission, of children using artemether-lumefantrine combination, we assessed the therapeutic efficacy of the medicine. "
01/01/2012 - "Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana."
10/01/2014 - "We sought to theoretically assess if Coartem can bring improvement in the treatment of malaria as compared to the other drugs. "
10/01/2014 - "This study analysed the dynamics of blood stage malaria with immune response and under administration of Coartem as a combination therapy. "
02/01/2013 - "It is marketed in Europe as Riamet(®) (Novartis, Basel, Switzerland) and in malaria-endemic countries as Coartem(®) (Novartis). "
|2.||Falciparum Malaria (Plasmodium falciparum Malaria)
06/01/2003 - "We concluded that both DNP and Coartem/ Riamet were safe, well tolerated and highly efficacious in the treatment of acute uncomplicated falciparum malaria in Thailand."
01/01/2013 - "Seventy-three children below the age of five years with microscopically confirmed uncomplicated Plasmodium falciparum malaria and prescribed Coartem(®) during the normal outpatient department hours were included into the study on 27(th) of April to 15(th) of May 2009. "
09/01/2015 - "Information Education and Communication can Improve Adherence to Artemether-Lumefantrine Combination in Patients of Uncomplicated Falciparum Malaria."
02/01/2011 - "Artemether Lumefantrine combination therapy may be used safely and effectively in the management of acute uncomplicated falciparum malaria."
02/01/2011 - "To assess the in vivo efficacy and adverse effects of Artemether-lumefantrine combination in acute uncomplicated falciparum malaria. "
07/01/2009 - "falciparum infections from Malawi for pfmdr-1 copy number changes and SNPs associated with in vivo tolerance and poor in vitro sensitivity to the component drugs of Coartem. "
07/01/2006 - "After 28 days of follow-up, there were 2/61 (3.2%) recurrent parasitemias in the Coartem group and 4/64 (6.2%) in the ASAQ group (P = 0.72), all classified as re-infections after PCR genotyping (cure rate = 100% [95%CI: 94-100] in both groups). "
01/05/2010 - "Artemether/Lumefantrine (Coartem(R)) has been used as a first-line treatment for uncomplicated Plasmodium falciparum infection since 2004 in Ethiopia. "
04/01/2007 - "Coartem is a fixed-dose combination of artemether-lumefantrine that, given in six doses, provides effective treatment for children with uncomplicated Plasmodium falciparum infection in areas with highly endemic and multidrug-resistant malaria. "
04/01/2007 - "Adequate clinical and parasitological response (ACPR) was significantly higher in children treated with Coartem than in those treated with AQ+SP: the PCR-adjusted 28-day ACPR was 96.68% for Coartem and 79.35% for AQ+SP. Both treatments rapidly cleared parasitaemia and fever, although parasite clearance was significantly faster in children treated with Coartem. "
01/01/2008 - "Of the 100 women who completed the study, there was no statistically significant difference in clinical and parasitological response by Day 4. The mean fever clearance time 3.0 days with Lapdap versus 2.5 days with Coartem was comparable. "
01/01/2013 - "After direct treatment with an artemether-lumefantrine combination, patients were followed up on day 3, 7, 14, 21, 28 and any other day of recurrent fever. "
02/28/2006 - "The mean fever clearance time, mean asexual parasite clearance time and the cure rate in 28 days were 35.3 +/- 6. 4, 34.7 +/- 6.9 hours and 100% respectively in coartem group, and 32. "
01/01/2013 - "Of the parasite negative patients (non-malarial fevers), 186 (21.4%) received Coartem, 423 (48.6%) SP and 19 (2.1%) cotrimoxazole. "
|10.||benflumetol drug combination artemether
|1.||Fluid Therapy (Oral Rehydration Therapy)